Pregnancy outcomes associated with extended use of the 52-mg 20 mu g/day levonorgestrel-releasing intrauterine system beyond 60 months: A chart review of 776 women in Brazil

Bahamondes Luis; Fernandes Arlete; Valeria Bahamondes M.; Juliato Cassia T.; Ali Moazzam; Monteiro Ilza

首页> 外文期刊>Contraception >Pregnancy outcomes associated with extended use of the 52-mg 20 mu g/day levonorgestrel-releasing intrauterine system beyond 60 months: A chart review of 776 women in Brazil

【24h】

Pregnancy outcomes associated with extended use of the 52-mg 20 mu g/day levonorgestrel-releasing intrauterine system beyond 60 months: A chart review of 776 women in Brazil

机译：妊娠结局与延长使用52毫克20亩百左右的左右60个月释放宫内系统：巴西776名妇女的图表综述

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To assess the contraceptive performance of the 52-mg 20 mu g/day levonorgestrel-releasing intrauterine system (LNG-IUS, Mirena; Bayer Oy, Turku, Finland) among women who maintain the same device without changes after 60 months.

机译：目的：评估52毫克20μg/天左旋静电术中的避孕性能 - 释放宫内系统（LNG-IUS，Mirena; Bayer Oy，Turku，Finland）在60个月后没有变化的妇女中的女性中的女性。

著录项

来源
《Contraception》 |2018年第3期|共5页
作者
Bahamondes Luis; Fernandes Arlete; Valeria Bahamondes M.; Juliato Cassia T.; Ali Moazzam; Monteiro Ilza;
展开▼
作者单位

Univ Estadual Campinas Med Sch Dept Obstet &

Gynecol Family Planning Clin BR-13084971 Campinas;

Univ Estadual Campinas Med Sch Dept Obstet &

Gynecol Family Planning Clin BR-13084971 Campinas;

Univ Estadual Campinas Med Sch Dept Obstet &

Gynecol Family Planning Clin BR-13084971 Campinas;

Univ Estadual Campinas Med Sch Dept Obstet &

Gynecol Family Planning Clin BR-13084971 Campinas;

WHO Dept Reprod Hlth &

Res Ave Appia 20 CH-1211 Geneva 27 Switzerland;

Univ Estadual Campinas Med Sch Dept Obstet &

Gynecol Family Planning Clin BR-13084971 Campinas;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类个人卫生;
关键词
Levonorgestrel-releasing intrauterine system; Extended use; Clinical performance; Mirena;

机译：Levonorgestrel释放宫内系统;延长使用;临床表现;Mirena;

相似文献

外文文献

1. Pregnancy outcomes associated with extended use of the 52-mg 20 mu g/day levonorgestrel-releasing intrauterine system beyond 60 months: A chart review of 776 women in Brazil [J] . Bahamondes Luis, Fernandes Arlete, Valeria Bahamondes M., Contraception . 2018,第3期

机译：妊娠结局与延长使用52毫克20亩百左右的左右60个月释放宫内系统：巴西776名妇女的图表综述
2. Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months [J] . The European journal of contraception & reproductive health care: the official journal of the European Society of Contraception . 2020,第2期

机译：子宫内膜异位症相关的疼痛分数和生物标志物在Etonogestrel-释放的底切割植入物或52mg左旋血糖释放的宫内系统长达24个月
3. Safety and efficacy of a 52-mg levonorgestrel-releasing intrauterine system in women with cardiovascular disease [J] . Ueda Yusuke, Kamiya Chizuko A., Horiuchi Chinami, The journal of obstetrics and gynaecology research . 2019,第2期

机译：患有心血管疾病的妇女血管内系统的52mg左炔诺血糖静脉内系统的安全性和疗效
4. A systematic review of selected birth outcomes in diabetic women who received preconception care and/or used multivitamins prior to pregnancy. [D] . Garcia, Bobbiejean F. 2008

机译：对接受孕前护理和/或在怀孕前使用多种维生素的糖尿病妇女的部分出生结局进行系统评价。
5. Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling [O] . Moazzam Ali, Luis Bahamondes, Sihem Bent Landoulsi 2017

机译：除美国食品和药物管理局产品标签外释放依托孕酮的避孕植入物和20 µg左炔诺孕酮的宫内避孕系统的有效期延长了2年
6. Femilis® 60 Levonorgestrel-Releasing Intrauterine System–-A Review of 10 Years of Clinical Experience [O] . Dirk Wildemeersch, Amaury Andrade, Norman Goldstuck 2016

机译：Femilis®60左炔诺孕酮释放宫内节育系统 - 对10年临床经验的回顾

Pregnancy outcomes associated with extended use of the 52-mg 20 mu g/day levonorgestrel-releasing intrauterine system beyond 60 months: A chart review of 776 women in Brazil

摘要

著录项

相似文献

相关主题

期刊订阅